You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 9, September 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  EXPERIMENTAL SURGERY
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Survival of Cardiac Xenografts

Effect of Antithymocyte Serum and Enhancing Heteroantiserum

Robert J. Corry, MD; Stephen E. Kelley

Arch Surg. 1975;110(9):1143-1145.


Abstract

Rat hearts were transplanted to the abdomens of mice by primary vascular union, and sinus rhythm occurred a few minutes after perfusion of the rat coronary vessels with mouse arterial blood. Five groups of mice with rat heart transplants were studied to evaluate the effect of mouse antirat serum (MARS) and antithymocyte serum (ATS) on the survival of the xenografted hearts. When high-dose MARS was administered, hyperacute rejection occurred, while the administration of low-dose MARS doubled the survival time of the xenotransplant. Antithymocyte serum greatly prolonged the function and survival of the hearts, while the addition of "enhancing serum" to the ATS regimen did not procure longer survival over that achieved by ATS alone.



Author Affiliations

From the Transplantation Service, Department of Surgery, University of Iowa College of Medicine, Iowa City.


Footnotes

Accepted for publication Jan 17, 1975.

Reprint requests to Department of Surgery, University Hospitals, Iowa City, IA 52242 (Dr. Corry).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Permanent Survival of Fully MHC-Mismatched Islet Allografts by Targeting a Single Chemokine Receptor Pathway
Wang et al.
J. Immunol. 2005;175:6311-6318.
ABSTRACT | FULL TEXT  

Xenografts: Review of the Literature and Current Status
Council on Scientific Affairs
JAMA 1985;254:3353-3357.
ABSTRACT  

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance
Seino et al.
Proc. Natl. Acad. Sci. USA 2001;98:2577-2581.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.